Patient no. | Tumor site | T | N | G | ER, PgR | KI67 | PVI |
---|
1 | UO | 1c | 0 (sn) | 2 | 15%, 25% | 11% | No |
2 | LI | 1c | 0 (sn) | 3 | 0%, 0% | 70% | No |
3 | C | 1c (is) | 0 (sn) | 1 | 90%, 90% | 13% | No |
4 | S | 1c | 1a | 2 | 85%, 85% | 25% | No |
5 | UO | 2 | 1a | 2 | 30%, 0% | 27% | Yes |
6 | UO | 1b | 0(sn) | 1 | 90%, 90% | 8% | No |
- T, tumor size; N, axillary lymph nodes; G, tumor grade; ER, estrogen receptors; PgR, progesterone receptors; KI67, proliferative index; C, central; is, extended intraductal component associated; LI, lower inner; PVI, perivascular invasion; S, superior; sn, sentinel node; UO, upper outer.